Reply to the Comments on “GLM7—A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity”

Documenti analoghi

• GLM7 – A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity
  di: Zhihua Wang, et al.
  Pubblicazione: (2025)
• Comment on: “GLM7 – A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity”
  di: Yiquan Wang, et al.
  Pubblicazione: (2026)
• Comment on “GLM7 – A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity”
  di: Peikai Sun, et al.
  Pubblicazione: (2026)
• Reply to “Exploring Bacteria‐Based Cancer Immunotherapy”—Comment on “Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics”
  di: Eijiro Miyako
  Pubblicazione: (2025)
• Integrative Multi‐Omics and Routine Blood Analysis Using Deep Learning: Cost‐Effective Early Prediction of Chronic Disease Risks
  di: Zhibin Dong, et al.
  Pubblicazione: (2025)